TrialOncology research2023

Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study.

Sukran Senyurek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.